Global iPSC-Derived Islet Cell Therapy Supply, Demand and Key Producers, 2026-2032
The global iPSC-Derived Islet Cell Therapy market size is expected to reach $ 1058 million by 2032, rising at a market growth of 53.7% CAGR during the forecast period (2026-2032).
iPSC-Derived Islet Cell Therapy refers to regenerative medicine products in which somatic cells from autologous patients or donors are reprogrammed into induced pluripotent stem cells (iPSCs), and subsequently differentiated into islet-like cell clusters, ?-cell?enriched populations, or engineered islets composed of multiple endocrine cell types. These products are designed to replace or restore impaired pancreatic islet function in patients with diabetes. They are typically developed as injectable cell suspensions, islet-like cell cluster grafts, or implantable constructs combined with immune isolation devices or bioprinted scaffolds. Key development priorities include glucose-responsive insulin secretion, cellular composition consistency, control of residual undifferentiated cells, immune rejection management, scalable GMP manufacturing, and long-term safety. The overall gross margin is approximately 60%.
Demand for this therapy is primarily driven by the long-term burden of diabetes management, the shortage of donor-derived islets, and the inability of exogenous insulin therapy to restore endogenous glucose regulation. Emerging clinical and preclinical data are gradually expanding islet replacement therapy from a small population of high-risk type 1 diabetes patients toward a broader insulin-dependent diabetes population. As a result, hospitals, research institutions, and large pharmaceutical companies are increasingly interested in standardized, scalable regenerative islet products.
Product development is focused on three main technological pathways: first, autologous iPSC-derived islet cell therapy, which emphasizes immune compatibility and personalized efficacy; second, allogeneic off-the-shelf islet cell banks, which prioritize scalable manufacturing, standardized quality release, and cost efficiency; and third, integrated approaches combining gene-edited hypoimmunogenic cells, immune isolation devices, and bioprinted scaffolds, aiming to reduce or eliminate the need for long-term immunosuppression. Procurement and partnership evaluations typically focus on cell purity, ?-cell proportion, glucose-stimulated insulin secretion, release testing systems, cryostability, implant site compatibility, and long-term clinical durability.
Regionally, the United States and Europe are advancing through collaboration between large pharmaceutical companies, cell therapy developers, and device platform providers. China and Japan are also progressing rapidly, supported by strong iPSC technology foundations, active clinical research ecosystems, and favorable regenerative medicine policies. Key opportunities lie in GMP differentiation processes, master cell banks, immune protection strategies, implantable delivery systems, and companion diagnostic tools. Major risks include tumorigenicity, immune rejection, uncertain long-term efficacy, manufacturing scale-up challenges, pricing and reimbursement constraints, and regulatory approval timelines.
Report Scope
This report studies the global iPSC-Derived Islet Cell Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for iPSC-Derived Islet Cell Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of iPSC-Derived Islet Cell Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global iPSC-Derived Islet Cell Therapy total market, 2021-2032, (USD Million)
Global iPSC-Derived Islet Cell Therapy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: iPSC-Derived Islet Cell Therapy total market, key domestic companies, and share, (USD Million)
Global iPSC-Derived Islet Cell Therapy revenue by player, revenue and market share 2021-2026, (USD Million)
Global iPSC-Derived Islet Cell Therapy total market by Type, CAGR, 2021-2032, (USD Million)
Global iPSC-Derived Islet Cell Therapy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global iPSC-Derived Islet Cell Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Reprogenix Bioscience, Sana Biotechnology, Century Therapeutics, Evotec, Sernova, Aspect Biosystems, Novo Nordisk, Allele Biotechnology, SCM Lifescience, Creative Medical Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world iPSC-Derived Islet Cell Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global iPSC-Derived Islet Cell Therapy Market, By Region:
1. How big is the global iPSC-Derived Islet Cell Therapy market?
2. What is the demand of the global iPSC-Derived Islet Cell Therapy market?
3. What is the year over year growth of the global iPSC-Derived Islet Cell Therapy market?
4. What is the total value of the global iPSC-Derived Islet Cell Therapy market?
5. Who are the Major Players in the global iPSC-Derived Islet Cell Therapy market?
6. What are the growth factors driving the market demand?
iPSC-Derived Islet Cell Therapy refers to regenerative medicine products in which somatic cells from autologous patients or donors are reprogrammed into induced pluripotent stem cells (iPSCs), and subsequently differentiated into islet-like cell clusters, ?-cell?enriched populations, or engineered islets composed of multiple endocrine cell types. These products are designed to replace or restore impaired pancreatic islet function in patients with diabetes. They are typically developed as injectable cell suspensions, islet-like cell cluster grafts, or implantable constructs combined with immune isolation devices or bioprinted scaffolds. Key development priorities include glucose-responsive insulin secretion, cellular composition consistency, control of residual undifferentiated cells, immune rejection management, scalable GMP manufacturing, and long-term safety. The overall gross margin is approximately 60%.
Demand for this therapy is primarily driven by the long-term burden of diabetes management, the shortage of donor-derived islets, and the inability of exogenous insulin therapy to restore endogenous glucose regulation. Emerging clinical and preclinical data are gradually expanding islet replacement therapy from a small population of high-risk type 1 diabetes patients toward a broader insulin-dependent diabetes population. As a result, hospitals, research institutions, and large pharmaceutical companies are increasingly interested in standardized, scalable regenerative islet products.
Product development is focused on three main technological pathways: first, autologous iPSC-derived islet cell therapy, which emphasizes immune compatibility and personalized efficacy; second, allogeneic off-the-shelf islet cell banks, which prioritize scalable manufacturing, standardized quality release, and cost efficiency; and third, integrated approaches combining gene-edited hypoimmunogenic cells, immune isolation devices, and bioprinted scaffolds, aiming to reduce or eliminate the need for long-term immunosuppression. Procurement and partnership evaluations typically focus on cell purity, ?-cell proportion, glucose-stimulated insulin secretion, release testing systems, cryostability, implant site compatibility, and long-term clinical durability.
Regionally, the United States and Europe are advancing through collaboration between large pharmaceutical companies, cell therapy developers, and device platform providers. China and Japan are also progressing rapidly, supported by strong iPSC technology foundations, active clinical research ecosystems, and favorable regenerative medicine policies. Key opportunities lie in GMP differentiation processes, master cell banks, immune protection strategies, implantable delivery systems, and companion diagnostic tools. Major risks include tumorigenicity, immune rejection, uncertain long-term efficacy, manufacturing scale-up challenges, pricing and reimbursement constraints, and regulatory approval timelines.
Report Scope
This report studies the global iPSC-Derived Islet Cell Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for iPSC-Derived Islet Cell Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of iPSC-Derived Islet Cell Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global iPSC-Derived Islet Cell Therapy total market, 2021-2032, (USD Million)
Global iPSC-Derived Islet Cell Therapy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: iPSC-Derived Islet Cell Therapy total market, key domestic companies, and share, (USD Million)
Global iPSC-Derived Islet Cell Therapy revenue by player, revenue and market share 2021-2026, (USD Million)
Global iPSC-Derived Islet Cell Therapy total market by Type, CAGR, 2021-2032, (USD Million)
Global iPSC-Derived Islet Cell Therapy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global iPSC-Derived Islet Cell Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Reprogenix Bioscience, Sana Biotechnology, Century Therapeutics, Evotec, Sernova, Aspect Biosystems, Novo Nordisk, Allele Biotechnology, SCM Lifescience, Creative Medical Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world iPSC-Derived Islet Cell Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global iPSC-Derived Islet Cell Therapy Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Autologous iPSC-Derived Islet Cell Therapy
- HLA-Matched Allogeneic iPSC-Derived Islet Cell Therapy
- Universal Allogeneic iPSC-Derived Islet Cell Therapy
- Beta Cell-Enriched Clusters
- Islet-Like Clusters
- Endocrine Subtype-Complete Islets
- Pancreatic Islet Organoids
- Immunosuppression-Dependent Therapy
- Encapsulation-Protected Therapy
- Hypoimmune Gene-Edited Therapy
- Autologous Immune-Matched Therapy
- Portal Vein or Liver Site
- Subcutaneous Site
- Intramuscular Site
- Omental Site
- Other Implantation Sites
- Type 1 Diabetes
- Type 2 Diabetes
- Pancreatogenic Diabetes
- Monogenic or Special Diabetes
- Preclinical Research
- Other
- Reprogenix Bioscience
- Sana Biotechnology
- Century Therapeutics
- Evotec
- Sernova
- Aspect Biosystems
- Novo Nordisk
- Allele Biotechnology
- SCM Lifescience
- Creative Medical Technology
1. How big is the global iPSC-Derived Islet Cell Therapy market?
2. What is the demand of the global iPSC-Derived Islet Cell Therapy market?
3. What is the year over year growth of the global iPSC-Derived Islet Cell Therapy market?
4. What is the total value of the global iPSC-Derived Islet Cell Therapy market?
5. Who are the Major Players in the global iPSC-Derived Islet Cell Therapy market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 iPSC-Derived Islet Cell Therapy Introduction
1.2 World iPSC-Derived Islet Cell Therapy Market Size & Forecast (2021 & 2025 & 2032)
1.3 World iPSC-Derived Islet Cell Therapy Total Market by Region (by Headquarter Location)
1.3.1 World iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.3 China Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.4 Europe Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.5 Japan Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.6 South Korea Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.7 ASEAN Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.8 India Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 iPSC-Derived Islet Cell Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.2 World iPSC-Derived Islet Cell Therapy Consumption Value by Region
2.2.1 World iPSC-Derived Islet Cell Therapy Consumption Value by Region (2021-2026)
2.2.2 World iPSC-Derived Islet Cell Therapy Consumption Value Forecast by Region (2027-2032)
2.3 United States iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.4 China iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.5 Europe iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.6 Japan iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.7 South Korea iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.8 ASEAN iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.9 India iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
3 WORLD IPSC-DERIVED ISLET CELL THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World iPSC-Derived Islet Cell Therapy Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global iPSC-Derived Islet Cell Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for iPSC-Derived Islet Cell Therapy in 2025
3.2.3 Global Concentration Ratios (CR8) for iPSC-Derived Islet Cell Therapy in 2025
3.3 iPSC-Derived Islet Cell Therapy Company Evaluation Quadrant
3.4 iPSC-Derived Islet Cell Therapy Market: Overall Company Footprint Analysis
3.4.1 iPSC-Derived Islet Cell Therapy Market: Region Footprint
3.4.2 iPSC-Derived Islet Cell Therapy Market: Company Product Type Footprint
3.4.3 iPSC-Derived Islet Cell Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: iPSC-Derived Islet Cell Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: iPSC-Derived Islet Cell Therapy Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: iPSC-Derived Islet Cell Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: iPSC-Derived Islet Cell Therapy Consumption Value Comparison
4.2.1 United States VS China: iPSC-Derived Islet Cell Therapy Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: iPSC-Derived Islet Cell Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based iPSC-Derived Islet Cell Therapy Companies and Market Share, 2021-2026
4.3.1 United States Based iPSC-Derived Islet Cell Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies iPSC-Derived Islet Cell Therapy Revenue, (2021-2026)
4.4 China Based Companies iPSC-Derived Islet Cell Therapy Revenue and Market Share, 2021-2026
4.4.1 China Based iPSC-Derived Islet Cell Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies iPSC-Derived Islet Cell Therapy Revenue, (2021-2026)
4.5 Rest of World Based iPSC-Derived Islet Cell Therapy Companies and Market Share, 2021-2026
4.5.1 Rest of World Based iPSC-Derived Islet Cell Therapy Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies iPSC-Derived Islet Cell Therapy Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World iPSC-Derived Islet Cell Therapy Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Autologous iPSC-Derived Islet Cell Therapy
5.2.2 HLA-Matched Allogeneic iPSC-Derived Islet Cell Therapy
5.2.3 Universal Allogeneic iPSC-Derived Islet Cell Therapy
5.3 Market Segment by Type
5.3.1 World iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026)
5.3.2 World iPSC-Derived Islet Cell Therapy Market Size by Type (2027-2032)
5.3.3 World iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY CELL COMPOSITION
6.1 World iPSC-Derived Islet Cell Therapy Market Size Overview by Cell Composition: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Cell Composition
6.2.1 Beta Cell-Enriched Clusters
6.2.2 Islet-Like Clusters
6.2.3 Endocrine Subtype-Complete Islets
6.2.4 Pancreatic Islet Organoids
6.3 Market Segment by Cell Composition
6.3.1 World iPSC-Derived Islet Cell Therapy Market Size by Cell Composition (2021-2026)
6.3.2 World iPSC-Derived Islet Cell Therapy Market Size by Cell Composition (2027-2032)
6.3.3 World iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Composition (2027-2032)
7 MARKET ANALYSIS BY IMMUNE PROTECTION STRATEGY
7.1 World iPSC-Derived Islet Cell Therapy Market Size Overview by Immune Protection Strategy: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Immune Protection Strategy
7.2.1 Immunosuppression-Dependent Therapy
7.2.2 Encapsulation-Protected Therapy
7.2.3 Hypoimmune Gene-Edited Therapy
7.2.4 Autologous Immune-Matched Therapy
7.3 Market Segment by Immune Protection Strategy
7.3.1 World iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy (2021-2026)
7.3.2 World iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy (2027-2032)
7.3.3 World iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy (2027-2032)
8 MARKET ANALYSIS BY TRANSPLANTATION SITE
8.1 World iPSC-Derived Islet Cell Therapy Market Size Overview by Transplantation Site: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Transplantation Site
8.2.1 Portal Vein or Liver Site
8.2.2 Subcutaneous Site
8.2.3 Intramuscular Site
8.2.4 Omental Site
8.2.5 Other Implantation Sites
8.3 Market Segment by Transplantation Site
8.3.1 World iPSC-Derived Islet Cell Therapy Market Size by Transplantation Site (2021-2026)
8.3.2 World iPSC-Derived Islet Cell Therapy Market Size by Transplantation Site (2027-2032)
8.3.3 World iPSC-Derived Islet Cell Therapy Market Size Market Share by Transplantation Site (2027-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World iPSC-Derived Islet Cell Therapy Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Type 1 Diabetes
9.2.2 Type 2 Diabetes
9.2.3 Pancreatogenic Diabetes
9.2.4 Monogenic or Special Diabetes
9.2.5 Preclinical Research
9.2.6 Other
9.3 Market Segment by Application
9.3.1 World iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026)
9.3.2 World iPSC-Derived Islet Cell Therapy Market Size by Application (2027-2032)
9.3.3 World iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2032)
10 COMPANY PROFILES
10.1 Reprogenix Bioscience
10.1.1 Reprogenix Bioscience Details
10.1.2 Reprogenix Bioscience Major Business
10.1.3 Reprogenix Bioscience iPSC-Derived Islet Cell Therapy Product and Services
10.1.4 Reprogenix Bioscience iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.1.5 Reprogenix Bioscience Recent Developments/Updates
10.1.6 Reprogenix Bioscience Competitive Strengths & Weaknesses
10.2 Sana Biotechnology
10.2.1 Sana Biotechnology Details
10.2.2 Sana Biotechnology Major Business
10.2.3 Sana Biotechnology iPSC-Derived Islet Cell Therapy Product and Services
10.2.4 Sana Biotechnology iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.2.5 Sana Biotechnology Recent Developments/Updates
10.2.6 Sana Biotechnology Competitive Strengths & Weaknesses
10.3 Century Therapeutics
10.3.1 Century Therapeutics Details
10.3.2 Century Therapeutics Major Business
10.3.3 Century Therapeutics iPSC-Derived Islet Cell Therapy Product and Services
10.3.4 Century Therapeutics iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.3.5 Century Therapeutics Recent Developments/Updates
10.3.6 Century Therapeutics Competitive Strengths & Weaknesses
10.4 Evotec
10.4.1 Evotec Details
10.4.2 Evotec Major Business
10.4.3 Evotec iPSC-Derived Islet Cell Therapy Product and Services
10.4.4 Evotec iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.4.5 Evotec Recent Developments/Updates
10.4.6 Evotec Competitive Strengths & Weaknesses
10.5 Sernova
10.5.1 Sernova Details
10.5.2 Sernova Major Business
10.5.3 Sernova iPSC-Derived Islet Cell Therapy Product and Services
10.5.4 Sernova iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.5.5 Sernova Recent Developments/Updates
10.5.6 Sernova Competitive Strengths & Weaknesses
10.6 Aspect Biosystems
10.6.1 Aspect Biosystems Details
10.6.2 Aspect Biosystems Major Business
10.6.3 Aspect Biosystems iPSC-Derived Islet Cell Therapy Product and Services
10.6.4 Aspect Biosystems iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.6.5 Aspect Biosystems Recent Developments/Updates
10.6.6 Aspect Biosystems Competitive Strengths & Weaknesses
10.7 Novo Nordisk
10.7.1 Novo Nordisk Details
10.7.2 Novo Nordisk Major Business
10.7.3 Novo Nordisk iPSC-Derived Islet Cell Therapy Product and Services
10.7.4 Novo Nordisk iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.7.5 Novo Nordisk Recent Developments/Updates
10.7.6 Novo Nordisk Competitive Strengths & Weaknesses
10.8 Allele Biotechnology
10.8.1 Allele Biotechnology Details
10.8.2 Allele Biotechnology Major Business
10.8.3 Allele Biotechnology iPSC-Derived Islet Cell Therapy Product and Services
10.8.4 Allele Biotechnology iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.8.5 Allele Biotechnology Recent Developments/Updates
10.8.6 Allele Biotechnology Competitive Strengths & Weaknesses
10.9 SCM Lifescience
10.9.1 SCM Lifescience Details
10.9.2 SCM Lifescience Major Business
10.9.3 SCM Lifescience iPSC-Derived Islet Cell Therapy Product and Services
10.9.4 SCM Lifescience iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.9.5 SCM Lifescience Recent Developments/Updates
10.9.6 SCM Lifescience Competitive Strengths & Weaknesses
10.10 Creative Medical Technology
10.10.1 Creative Medical Technology Details
10.10.2 Creative Medical Technology Major Business
10.10.3 Creative Medical Technology iPSC-Derived Islet Cell Therapy Product and Services
10.10.4 Creative Medical Technology iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.10.5 Creative Medical Technology Recent Developments/Updates
10.10.6 Creative Medical Technology Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 iPSC-Derived Islet Cell Therapy Industry Chain
11.2 iPSC-Derived Islet Cell Therapy Upstream Analysis
11.3 iPSC-Derived Islet Cell Therapy Midstream Analysis
11.4 iPSC-Derived Islet Cell Therapy Downstream Analysis
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 iPSC-Derived Islet Cell Therapy Introduction
1.2 World iPSC-Derived Islet Cell Therapy Market Size & Forecast (2021 & 2025 & 2032)
1.3 World iPSC-Derived Islet Cell Therapy Total Market by Region (by Headquarter Location)
1.3.1 World iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.3 China Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.4 Europe Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.5 Japan Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.6 South Korea Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.7 ASEAN Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.8 India Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 iPSC-Derived Islet Cell Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.2 World iPSC-Derived Islet Cell Therapy Consumption Value by Region
2.2.1 World iPSC-Derived Islet Cell Therapy Consumption Value by Region (2021-2026)
2.2.2 World iPSC-Derived Islet Cell Therapy Consumption Value Forecast by Region (2027-2032)
2.3 United States iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.4 China iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.5 Europe iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.6 Japan iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.7 South Korea iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.8 ASEAN iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.9 India iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
3 WORLD IPSC-DERIVED ISLET CELL THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World iPSC-Derived Islet Cell Therapy Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global iPSC-Derived Islet Cell Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for iPSC-Derived Islet Cell Therapy in 2025
3.2.3 Global Concentration Ratios (CR8) for iPSC-Derived Islet Cell Therapy in 2025
3.3 iPSC-Derived Islet Cell Therapy Company Evaluation Quadrant
3.4 iPSC-Derived Islet Cell Therapy Market: Overall Company Footprint Analysis
3.4.1 iPSC-Derived Islet Cell Therapy Market: Region Footprint
3.4.2 iPSC-Derived Islet Cell Therapy Market: Company Product Type Footprint
3.4.3 iPSC-Derived Islet Cell Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: iPSC-Derived Islet Cell Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: iPSC-Derived Islet Cell Therapy Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: iPSC-Derived Islet Cell Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: iPSC-Derived Islet Cell Therapy Consumption Value Comparison
4.2.1 United States VS China: iPSC-Derived Islet Cell Therapy Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: iPSC-Derived Islet Cell Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based iPSC-Derived Islet Cell Therapy Companies and Market Share, 2021-2026
4.3.1 United States Based iPSC-Derived Islet Cell Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies iPSC-Derived Islet Cell Therapy Revenue, (2021-2026)
4.4 China Based Companies iPSC-Derived Islet Cell Therapy Revenue and Market Share, 2021-2026
4.4.1 China Based iPSC-Derived Islet Cell Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies iPSC-Derived Islet Cell Therapy Revenue, (2021-2026)
4.5 Rest of World Based iPSC-Derived Islet Cell Therapy Companies and Market Share, 2021-2026
4.5.1 Rest of World Based iPSC-Derived Islet Cell Therapy Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies iPSC-Derived Islet Cell Therapy Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World iPSC-Derived Islet Cell Therapy Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Autologous iPSC-Derived Islet Cell Therapy
5.2.2 HLA-Matched Allogeneic iPSC-Derived Islet Cell Therapy
5.2.3 Universal Allogeneic iPSC-Derived Islet Cell Therapy
5.3 Market Segment by Type
5.3.1 World iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026)
5.3.2 World iPSC-Derived Islet Cell Therapy Market Size by Type (2027-2032)
5.3.3 World iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY CELL COMPOSITION
6.1 World iPSC-Derived Islet Cell Therapy Market Size Overview by Cell Composition: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Cell Composition
6.2.1 Beta Cell-Enriched Clusters
6.2.2 Islet-Like Clusters
6.2.3 Endocrine Subtype-Complete Islets
6.2.4 Pancreatic Islet Organoids
6.3 Market Segment by Cell Composition
6.3.1 World iPSC-Derived Islet Cell Therapy Market Size by Cell Composition (2021-2026)
6.3.2 World iPSC-Derived Islet Cell Therapy Market Size by Cell Composition (2027-2032)
6.3.3 World iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Composition (2027-2032)
7 MARKET ANALYSIS BY IMMUNE PROTECTION STRATEGY
7.1 World iPSC-Derived Islet Cell Therapy Market Size Overview by Immune Protection Strategy: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Immune Protection Strategy
7.2.1 Immunosuppression-Dependent Therapy
7.2.2 Encapsulation-Protected Therapy
7.2.3 Hypoimmune Gene-Edited Therapy
7.2.4 Autologous Immune-Matched Therapy
7.3 Market Segment by Immune Protection Strategy
7.3.1 World iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy (2021-2026)
7.3.2 World iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy (2027-2032)
7.3.3 World iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy (2027-2032)
8 MARKET ANALYSIS BY TRANSPLANTATION SITE
8.1 World iPSC-Derived Islet Cell Therapy Market Size Overview by Transplantation Site: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Transplantation Site
8.2.1 Portal Vein or Liver Site
8.2.2 Subcutaneous Site
8.2.3 Intramuscular Site
8.2.4 Omental Site
8.2.5 Other Implantation Sites
8.3 Market Segment by Transplantation Site
8.3.1 World iPSC-Derived Islet Cell Therapy Market Size by Transplantation Site (2021-2026)
8.3.2 World iPSC-Derived Islet Cell Therapy Market Size by Transplantation Site (2027-2032)
8.3.3 World iPSC-Derived Islet Cell Therapy Market Size Market Share by Transplantation Site (2027-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World iPSC-Derived Islet Cell Therapy Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Type 1 Diabetes
9.2.2 Type 2 Diabetes
9.2.3 Pancreatogenic Diabetes
9.2.4 Monogenic or Special Diabetes
9.2.5 Preclinical Research
9.2.6 Other
9.3 Market Segment by Application
9.3.1 World iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026)
9.3.2 World iPSC-Derived Islet Cell Therapy Market Size by Application (2027-2032)
9.3.3 World iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2032)
10 COMPANY PROFILES
10.1 Reprogenix Bioscience
10.1.1 Reprogenix Bioscience Details
10.1.2 Reprogenix Bioscience Major Business
10.1.3 Reprogenix Bioscience iPSC-Derived Islet Cell Therapy Product and Services
10.1.4 Reprogenix Bioscience iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.1.5 Reprogenix Bioscience Recent Developments/Updates
10.1.6 Reprogenix Bioscience Competitive Strengths & Weaknesses
10.2 Sana Biotechnology
10.2.1 Sana Biotechnology Details
10.2.2 Sana Biotechnology Major Business
10.2.3 Sana Biotechnology iPSC-Derived Islet Cell Therapy Product and Services
10.2.4 Sana Biotechnology iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.2.5 Sana Biotechnology Recent Developments/Updates
10.2.6 Sana Biotechnology Competitive Strengths & Weaknesses
10.3 Century Therapeutics
10.3.1 Century Therapeutics Details
10.3.2 Century Therapeutics Major Business
10.3.3 Century Therapeutics iPSC-Derived Islet Cell Therapy Product and Services
10.3.4 Century Therapeutics iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.3.5 Century Therapeutics Recent Developments/Updates
10.3.6 Century Therapeutics Competitive Strengths & Weaknesses
10.4 Evotec
10.4.1 Evotec Details
10.4.2 Evotec Major Business
10.4.3 Evotec iPSC-Derived Islet Cell Therapy Product and Services
10.4.4 Evotec iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.4.5 Evotec Recent Developments/Updates
10.4.6 Evotec Competitive Strengths & Weaknesses
10.5 Sernova
10.5.1 Sernova Details
10.5.2 Sernova Major Business
10.5.3 Sernova iPSC-Derived Islet Cell Therapy Product and Services
10.5.4 Sernova iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.5.5 Sernova Recent Developments/Updates
10.5.6 Sernova Competitive Strengths & Weaknesses
10.6 Aspect Biosystems
10.6.1 Aspect Biosystems Details
10.6.2 Aspect Biosystems Major Business
10.6.3 Aspect Biosystems iPSC-Derived Islet Cell Therapy Product and Services
10.6.4 Aspect Biosystems iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.6.5 Aspect Biosystems Recent Developments/Updates
10.6.6 Aspect Biosystems Competitive Strengths & Weaknesses
10.7 Novo Nordisk
10.7.1 Novo Nordisk Details
10.7.2 Novo Nordisk Major Business
10.7.3 Novo Nordisk iPSC-Derived Islet Cell Therapy Product and Services
10.7.4 Novo Nordisk iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.7.5 Novo Nordisk Recent Developments/Updates
10.7.6 Novo Nordisk Competitive Strengths & Weaknesses
10.8 Allele Biotechnology
10.8.1 Allele Biotechnology Details
10.8.2 Allele Biotechnology Major Business
10.8.3 Allele Biotechnology iPSC-Derived Islet Cell Therapy Product and Services
10.8.4 Allele Biotechnology iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.8.5 Allele Biotechnology Recent Developments/Updates
10.8.6 Allele Biotechnology Competitive Strengths & Weaknesses
10.9 SCM Lifescience
10.9.1 SCM Lifescience Details
10.9.2 SCM Lifescience Major Business
10.9.3 SCM Lifescience iPSC-Derived Islet Cell Therapy Product and Services
10.9.4 SCM Lifescience iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.9.5 SCM Lifescience Recent Developments/Updates
10.9.6 SCM Lifescience Competitive Strengths & Weaknesses
10.10 Creative Medical Technology
10.10.1 Creative Medical Technology Details
10.10.2 Creative Medical Technology Major Business
10.10.3 Creative Medical Technology iPSC-Derived Islet Cell Therapy Product and Services
10.10.4 Creative Medical Technology iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.10.5 Creative Medical Technology Recent Developments/Updates
10.10.6 Creative Medical Technology Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 iPSC-Derived Islet Cell Therapy Industry Chain
11.2 iPSC-Derived Islet Cell Therapy Upstream Analysis
11.3 iPSC-Derived Islet Cell Therapy Midstream Analysis
11.4 iPSC-Derived Islet Cell Therapy Downstream Analysis
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World iPSC-Derived Islet Cell Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World iPSC-Derived Islet Cell Therapy Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World iPSC-Derived Islet Cell Therapy Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World iPSC-Derived Islet Cell Therapy Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World iPSC-Derived Islet Cell Therapy Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World iPSC-Derived Islet Cell Therapy Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World iPSC-Derived Islet Cell Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World iPSC-Derived Islet Cell Therapy Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World iPSC-Derived Islet Cell Therapy Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key iPSC-Derived Islet Cell Therapy Players in 2025
Table 12. World iPSC-Derived Islet Cell Therapy Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global iPSC-Derived Islet Cell Therapy Company Evaluation Quadrant
Table 14. Head Office of Key iPSC-Derived Islet Cell Therapy Players
Table 15. iPSC-Derived Islet Cell Therapy Market: Company Product Type Footprint
Table 16. iPSC-Derived Islet Cell Therapy Market: Company Product Application Footprint
Table 17. iPSC-Derived Islet Cell Therapy Mergers & Acquisitions Activity
Table 18. United States VS China iPSC-Derived Islet Cell Therapy Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China iPSC-Derived Islet Cell Therapy Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based iPSC-Derived Islet Cell Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies iPSC-Derived Islet Cell Therapy Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies iPSC-Derived Islet Cell Therapy Revenue Market Share (2021-2026)
Table 23. China Based iPSC-Derived Islet Cell Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies iPSC-Derived Islet Cell Therapy Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies iPSC-Derived Islet Cell Therapy Revenue Market Share (2021-2026)
Table 26. Rest of World Based iPSC-Derived Islet Cell Therapy Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies iPSC-Derived Islet Cell Therapy Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies iPSC-Derived Islet Cell Therapy Revenue Market Share (2021-2026)
Table 29. World iPSC-Derived Islet Cell Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World iPSC-Derived Islet Cell Therapy Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World iPSC-Derived Islet Cell Therapy Market Size by Type (2027-2032) & (USD Million)
Table 32. World iPSC-Derived Islet Cell Therapy Market Size by Cell Composition, (USD Million), 2021 & 2025 & 2032
Table 33. World iPSC-Derived Islet Cell Therapy Market Size Value by Cell Composition (2021-2026) & (USD Million)
Table 34. World iPSC-Derived Islet Cell Therapy Market Size by Cell Composition (2027-2032) & (USD Million)
Table 35. World iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy, (USD Million), 2021 & 2025 & 2032
Table 36. World iPSC-Derived Islet Cell Therapy Market Size Value by Immune Protection Strategy (2021-2026) & (USD Million)
Table 37. World iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy (2027-2032) & (USD Million)
Table 38. World iPSC-Derived Islet Cell Therapy Market Size by Transplantation Site, (USD Million), 2021 & 2025 & 2032
Table 39. World iPSC-Derived Islet Cell Therapy Market Size Value by Transplantation Site (2021-2026) & (USD Million)
Table 40. World iPSC-Derived Islet Cell Therapy Market Size by Transplantation Site (2027-2032) & (USD Million)
Table 41. World iPSC-Derived Islet Cell Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 42. World iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & (USD Million)
Table 43. World iPSC-Derived Islet Cell Therapy Market Size by Application (2027-2032) & (USD Million)
Table 44. Reprogenix Bioscience Basic Information, Manufacturing Base and Competitors
Table 45. Reprogenix Bioscience Major Business
Table 46. Reprogenix Bioscience iPSC-Derived Islet Cell Therapy Product and Services
Table 47. Reprogenix Bioscience iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Reprogenix Bioscience Recent Developments/Updates
Table 49. Reprogenix Bioscience Competitive Strengths & Weaknesses
Table 50. Sana Biotechnology Basic Information, Manufacturing Base and Competitors
Table 51. Sana Biotechnology Major Business
Table 52. Sana Biotechnology iPSC-Derived Islet Cell Therapy Product and Services
Table 53. Sana Biotechnology iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Sana Biotechnology Recent Developments/Updates
Table 55. Sana Biotechnology Competitive Strengths & Weaknesses
Table 56. Century Therapeutics Basic Information, Manufacturing Base and Competitors
Table 57. Century Therapeutics Major Business
Table 58. Century Therapeutics iPSC-Derived Islet Cell Therapy Product and Services
Table 59. Century Therapeutics iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Century Therapeutics Recent Developments/Updates
Table 61. Century Therapeutics Competitive Strengths & Weaknesses
Table 62. Evotec Basic Information, Manufacturing Base and Competitors
Table 63. Evotec Major Business
Table 64. Evotec iPSC-Derived Islet Cell Therapy Product and Services
Table 65. Evotec iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Evotec Recent Developments/Updates
Table 67. Evotec Competitive Strengths & Weaknesses
Table 68. Sernova Basic Information, Manufacturing Base and Competitors
Table 69. Sernova Major Business
Table 70. Sernova iPSC-Derived Islet Cell Therapy Product and Services
Table 71. Sernova iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Sernova Recent Developments/Updates
Table 73. Sernova Competitive Strengths & Weaknesses
Table 74. Aspect Biosystems Basic Information, Manufacturing Base and Competitors
Table 75. Aspect Biosystems Major Business
Table 76. Aspect Biosystems iPSC-Derived Islet Cell Therapy Product and Services
Table 77. Aspect Biosystems iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Aspect Biosystems Recent Developments/Updates
Table 79. Aspect Biosystems Competitive Strengths & Weaknesses
Table 80. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 81. Novo Nordisk Major Business
Table 82. Novo Nordisk iPSC-Derived Islet Cell Therapy Product and Services
Table 83. Novo Nordisk iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Novo Nordisk Recent Developments/Updates
Table 85. Novo Nordisk Competitive Strengths & Weaknesses
Table 86. Allele Biotechnology Basic Information, Manufacturing Base and Competitors
Table 87. Allele Biotechnology Major Business
Table 88. Allele Biotechnology iPSC-Derived Islet Cell Therapy Product and Services
Table 89. Allele Biotechnology iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Allele Biotechnology Recent Developments/Updates
Table 91. Allele Biotechnology Competitive Strengths & Weaknesses
Table 92. SCM Lifescience Basic Information, Manufacturing Base and Competitors
Table 93. SCM Lifescience Major Business
Table 94. SCM Lifescience iPSC-Derived Islet Cell Therapy Product and Services
Table 95. SCM Lifescience iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. SCM Lifescience Recent Developments/Updates
Table 97. SCM Lifescience Competitive Strengths & Weaknesses
Table 98. Creative Medical Technology Basic Information, Manufacturing Base and Competitors
Table 99. Creative Medical Technology Major Business
Table 100. Creative Medical Technology iPSC-Derived Islet Cell Therapy Product and Services
Table 101. Creative Medical Technology iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Creative Medical Technology Recent Developments/Updates
Table 103. Creative Medical Technology Competitive Strengths & Weaknesses
Table 104. Global Key Players of iPSC-Derived Islet Cell Therapy Upstream (Raw Materials)
Table 105. Global iPSC-Derived Islet Cell Therapy Typical Customers
Table 1. World iPSC-Derived Islet Cell Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World iPSC-Derived Islet Cell Therapy Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World iPSC-Derived Islet Cell Therapy Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World iPSC-Derived Islet Cell Therapy Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World iPSC-Derived Islet Cell Therapy Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World iPSC-Derived Islet Cell Therapy Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World iPSC-Derived Islet Cell Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World iPSC-Derived Islet Cell Therapy Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World iPSC-Derived Islet Cell Therapy Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key iPSC-Derived Islet Cell Therapy Players in 2025
Table 12. World iPSC-Derived Islet Cell Therapy Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global iPSC-Derived Islet Cell Therapy Company Evaluation Quadrant
Table 14. Head Office of Key iPSC-Derived Islet Cell Therapy Players
Table 15. iPSC-Derived Islet Cell Therapy Market: Company Product Type Footprint
Table 16. iPSC-Derived Islet Cell Therapy Market: Company Product Application Footprint
Table 17. iPSC-Derived Islet Cell Therapy Mergers & Acquisitions Activity
Table 18. United States VS China iPSC-Derived Islet Cell Therapy Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China iPSC-Derived Islet Cell Therapy Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based iPSC-Derived Islet Cell Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies iPSC-Derived Islet Cell Therapy Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies iPSC-Derived Islet Cell Therapy Revenue Market Share (2021-2026)
Table 23. China Based iPSC-Derived Islet Cell Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies iPSC-Derived Islet Cell Therapy Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies iPSC-Derived Islet Cell Therapy Revenue Market Share (2021-2026)
Table 26. Rest of World Based iPSC-Derived Islet Cell Therapy Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies iPSC-Derived Islet Cell Therapy Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies iPSC-Derived Islet Cell Therapy Revenue Market Share (2021-2026)
Table 29. World iPSC-Derived Islet Cell Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World iPSC-Derived Islet Cell Therapy Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World iPSC-Derived Islet Cell Therapy Market Size by Type (2027-2032) & (USD Million)
Table 32. World iPSC-Derived Islet Cell Therapy Market Size by Cell Composition, (USD Million), 2021 & 2025 & 2032
Table 33. World iPSC-Derived Islet Cell Therapy Market Size Value by Cell Composition (2021-2026) & (USD Million)
Table 34. World iPSC-Derived Islet Cell Therapy Market Size by Cell Composition (2027-2032) & (USD Million)
Table 35. World iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy, (USD Million), 2021 & 2025 & 2032
Table 36. World iPSC-Derived Islet Cell Therapy Market Size Value by Immune Protection Strategy (2021-2026) & (USD Million)
Table 37. World iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy (2027-2032) & (USD Million)
Table 38. World iPSC-Derived Islet Cell Therapy Market Size by Transplantation Site, (USD Million), 2021 & 2025 & 2032
Table 39. World iPSC-Derived Islet Cell Therapy Market Size Value by Transplantation Site (2021-2026) & (USD Million)
Table 40. World iPSC-Derived Islet Cell Therapy Market Size by Transplantation Site (2027-2032) & (USD Million)
Table 41. World iPSC-Derived Islet Cell Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 42. World iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & (USD Million)
Table 43. World iPSC-Derived Islet Cell Therapy Market Size by Application (2027-2032) & (USD Million)
Table 44. Reprogenix Bioscience Basic Information, Manufacturing Base and Competitors
Table 45. Reprogenix Bioscience Major Business
Table 46. Reprogenix Bioscience iPSC-Derived Islet Cell Therapy Product and Services
Table 47. Reprogenix Bioscience iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Reprogenix Bioscience Recent Developments/Updates
Table 49. Reprogenix Bioscience Competitive Strengths & Weaknesses
Table 50. Sana Biotechnology Basic Information, Manufacturing Base and Competitors
Table 51. Sana Biotechnology Major Business
Table 52. Sana Biotechnology iPSC-Derived Islet Cell Therapy Product and Services
Table 53. Sana Biotechnology iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Sana Biotechnology Recent Developments/Updates
Table 55. Sana Biotechnology Competitive Strengths & Weaknesses
Table 56. Century Therapeutics Basic Information, Manufacturing Base and Competitors
Table 57. Century Therapeutics Major Business
Table 58. Century Therapeutics iPSC-Derived Islet Cell Therapy Product and Services
Table 59. Century Therapeutics iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Century Therapeutics Recent Developments/Updates
Table 61. Century Therapeutics Competitive Strengths & Weaknesses
Table 62. Evotec Basic Information, Manufacturing Base and Competitors
Table 63. Evotec Major Business
Table 64. Evotec iPSC-Derived Islet Cell Therapy Product and Services
Table 65. Evotec iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Evotec Recent Developments/Updates
Table 67. Evotec Competitive Strengths & Weaknesses
Table 68. Sernova Basic Information, Manufacturing Base and Competitors
Table 69. Sernova Major Business
Table 70. Sernova iPSC-Derived Islet Cell Therapy Product and Services
Table 71. Sernova iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Sernova Recent Developments/Updates
Table 73. Sernova Competitive Strengths & Weaknesses
Table 74. Aspect Biosystems Basic Information, Manufacturing Base and Competitors
Table 75. Aspect Biosystems Major Business
Table 76. Aspect Biosystems iPSC-Derived Islet Cell Therapy Product and Services
Table 77. Aspect Biosystems iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Aspect Biosystems Recent Developments/Updates
Table 79. Aspect Biosystems Competitive Strengths & Weaknesses
Table 80. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 81. Novo Nordisk Major Business
Table 82. Novo Nordisk iPSC-Derived Islet Cell Therapy Product and Services
Table 83. Novo Nordisk iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Novo Nordisk Recent Developments/Updates
Table 85. Novo Nordisk Competitive Strengths & Weaknesses
Table 86. Allele Biotechnology Basic Information, Manufacturing Base and Competitors
Table 87. Allele Biotechnology Major Business
Table 88. Allele Biotechnology iPSC-Derived Islet Cell Therapy Product and Services
Table 89. Allele Biotechnology iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Allele Biotechnology Recent Developments/Updates
Table 91. Allele Biotechnology Competitive Strengths & Weaknesses
Table 92. SCM Lifescience Basic Information, Manufacturing Base and Competitors
Table 93. SCM Lifescience Major Business
Table 94. SCM Lifescience iPSC-Derived Islet Cell Therapy Product and Services
Table 95. SCM Lifescience iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. SCM Lifescience Recent Developments/Updates
Table 97. SCM Lifescience Competitive Strengths & Weaknesses
Table 98. Creative Medical Technology Basic Information, Manufacturing Base and Competitors
Table 99. Creative Medical Technology Major Business
Table 100. Creative Medical Technology iPSC-Derived Islet Cell Therapy Product and Services
Table 101. Creative Medical Technology iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Creative Medical Technology Recent Developments/Updates
Table 103. Creative Medical Technology Competitive Strengths & Weaknesses
Table 104. Global Key Players of iPSC-Derived Islet Cell Therapy Upstream (Raw Materials)
Table 105. Global iPSC-Derived Islet Cell Therapy Typical Customers
LIST OF FIGURES
Figure 1. iPSC-Derived Islet Cell Therapy Picture
Figure 2. World iPSC-Derived Islet Cell Therapy Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World iPSC-Derived Islet Cell Therapy Total Revenue (2021-2032) & (USD Million)
Figure 4. World iPSC-Derived Islet Cell Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World iPSC-Derived Islet Cell Therapy Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 13. iPSC-Derived Islet Cell Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 16. World iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Region (2021-2032)
Figure 17. United States iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 18. China iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 23. India iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of iPSC-Derived Islet Cell Therapy by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for iPSC-Derived Islet Cell Therapy Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for iPSC-Derived Islet Cell Therapy Markets in 2025
Figure 27. United States VS China: iPSC-Derived Islet Cell Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: iPSC-Derived Islet Cell Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World iPSC-Derived Islet Cell Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World iPSC-Derived Islet Cell Therapy Market Size Market Share by Type in 2025
Figure 31. Autologous iPSC-Derived Islet Cell Therapy
Figure 32. HLA-Matched Allogeneic iPSC-Derived Islet Cell Therapy
Figure 33. Universal Allogeneic iPSC-Derived Islet Cell Therapy
Figure 34. World iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2032)
Figure 35. World iPSC-Derived Islet Cell Therapy Market Size by Cell Composition, (USD Million), 2021 & 2025 & 2032
Figure 36. World iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Composition in 2025
Figure 37. Beta Cell-Enriched Clusters
Figure 38. Islet-Like Clusters
Figure 39. Endocrine Subtype-Complete Islets
Figure 40. Pancreatic Islet Organoids
Figure 41. World iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Composition (2021-2032)
Figure 42. World iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy, (USD Million), 2021 & 2025 & 2032
Figure 43. World iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy in 2025
Figure 44. Immunosuppression-Dependent Therapy
Figure 45. Encapsulation-Protected Therapy
Figure 46. Hypoimmune Gene-Edited Therapy
Figure 47. Autologous Immune-Matched Therapy
Figure 48. World iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy (2021-2032)
Figure 49. World iPSC-Derived Islet Cell Therapy Market Size by Transplantation Site, (USD Million), 2021 & 2025 & 2032
Figure 50. World iPSC-Derived Islet Cell Therapy Market Size Market Share by Transplantation Site in 2025
Figure 51. Portal Vein or Liver Site
Figure 52. Subcutaneous Site
Figure 53. Intramuscular Site
Figure 54. Omental Site
Figure 55. Other Implantation Sites
Figure 56. World iPSC-Derived Islet Cell Therapy Market Size Market Share by Transplantation Site (2021-2032)
Figure 57. World iPSC-Derived Islet Cell Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 58. World iPSC-Derived Islet Cell Therapy Market Size Market Share by Application in 2025
Figure 59. Type 1 Diabetes
Figure 60. Type 2 Diabetes
Figure 61. Pancreatogenic Diabetes
Figure 62. Monogenic or Special Diabetes
Figure 63. Preclinical Research
Figure 64. Other
Figure 65. World iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2032)
Figure 66. iPSC-Derived Islet Cell Therapy Industrial Chain
Figure 67. Methodology
Figure 68. Research Process and Data Source
Figure 1. iPSC-Derived Islet Cell Therapy Picture
Figure 2. World iPSC-Derived Islet Cell Therapy Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World iPSC-Derived Islet Cell Therapy Total Revenue (2021-2032) & (USD Million)
Figure 4. World iPSC-Derived Islet Cell Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World iPSC-Derived Islet Cell Therapy Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 13. iPSC-Derived Islet Cell Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 16. World iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Region (2021-2032)
Figure 17. United States iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 18. China iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 23. India iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of iPSC-Derived Islet Cell Therapy by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for iPSC-Derived Islet Cell Therapy Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for iPSC-Derived Islet Cell Therapy Markets in 2025
Figure 27. United States VS China: iPSC-Derived Islet Cell Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: iPSC-Derived Islet Cell Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World iPSC-Derived Islet Cell Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World iPSC-Derived Islet Cell Therapy Market Size Market Share by Type in 2025
Figure 31. Autologous iPSC-Derived Islet Cell Therapy
Figure 32. HLA-Matched Allogeneic iPSC-Derived Islet Cell Therapy
Figure 33. Universal Allogeneic iPSC-Derived Islet Cell Therapy
Figure 34. World iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2032)
Figure 35. World iPSC-Derived Islet Cell Therapy Market Size by Cell Composition, (USD Million), 2021 & 2025 & 2032
Figure 36. World iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Composition in 2025
Figure 37. Beta Cell-Enriched Clusters
Figure 38. Islet-Like Clusters
Figure 39. Endocrine Subtype-Complete Islets
Figure 40. Pancreatic Islet Organoids
Figure 41. World iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Composition (2021-2032)
Figure 42. World iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy, (USD Million), 2021 & 2025 & 2032
Figure 43. World iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy in 2025
Figure 44. Immunosuppression-Dependent Therapy
Figure 45. Encapsulation-Protected Therapy
Figure 46. Hypoimmune Gene-Edited Therapy
Figure 47. Autologous Immune-Matched Therapy
Figure 48. World iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy (2021-2032)
Figure 49. World iPSC-Derived Islet Cell Therapy Market Size by Transplantation Site, (USD Million), 2021 & 2025 & 2032
Figure 50. World iPSC-Derived Islet Cell Therapy Market Size Market Share by Transplantation Site in 2025
Figure 51. Portal Vein or Liver Site
Figure 52. Subcutaneous Site
Figure 53. Intramuscular Site
Figure 54. Omental Site
Figure 55. Other Implantation Sites
Figure 56. World iPSC-Derived Islet Cell Therapy Market Size Market Share by Transplantation Site (2021-2032)
Figure 57. World iPSC-Derived Islet Cell Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 58. World iPSC-Derived Islet Cell Therapy Market Size Market Share by Application in 2025
Figure 59. Type 1 Diabetes
Figure 60. Type 2 Diabetes
Figure 61. Pancreatogenic Diabetes
Figure 62. Monogenic or Special Diabetes
Figure 63. Preclinical Research
Figure 64. Other
Figure 65. World iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2032)
Figure 66. iPSC-Derived Islet Cell Therapy Industrial Chain
Figure 67. Methodology
Figure 68. Research Process and Data Source
